Evanthia Galanis

Active 1997–2025

127
Papers
23,909
Citations
80
h-index
125
i10-index

Citations

Citations per year for Evanthia Galanis1986: 1 citations1993: 1 citations1998: 3 citations1999: 5 citations2000: 7 citations2001: 10 citations2002: 13 citations2003: 32 citations2004: 29 citations2005: 41 citations2006: 66 citations2007: 78 citations2008: 90 citations2009: 100 citations2010: 113 citations2011: 174 citations2012: 140 citations2013: 160 citations2014: 141 citations2015: 155 citations2016: 158 citations2017: 215 citations2018: 183 citations2019: 664 citations2020: 962 citations2021: 987 citations2022: 933 citations2023: 703 citations2024: 1,261 citations2025: 593 citations2026: 22 citations1987–1992: no citations, so these years are not shown1994–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,009 citing papers, 29.1% of this breakdownChina: 872 citing papers, 8.4% of this breakdownGermany: 804 citing papers, 7.8% of this breakdownUnited Kingdom: 551 citing papers, 5.3% of this breakdownItaly: 524 citing papers, 5.1% of this breakdownCanada: 411 citing papers, 4% of this breakdownFrance: 400 citing papers, 3.9% of this breakdownNetherlands: 379 citing papers, 3.7% of this breakdownSwitzerland: 358 citing papers, 3.5% of this breakdownSpain: 253 citing papers, 2.4% of this breakdownJapan: 200 citing papers, 1.9% of this breakdownSouth Korea: 200 citing papers, 1.9% of this breakdown
0%29.1%Other 23%

Fields

  • Medicine64%
  • Biochemistry, Genetics and Molecular Biology25%
  • Immunology and Microbiology2.7%
  • Neuroscience2.4%
  • Materials Science1.7%
  • Engineering1.5%
  • Other2.7%

Topics

  • Glioma Diagnosis and Treatment15.8%
  • Brain Metastases and Treatment7.3%
  • Virus-based gene therapy research3.6%
  • Meningioma and schwannoma management3.1%
  • Radiomics and Machine Learning in Medical Imaging2.7%
  • CAR-T cell therapy research2.4%
  • Other65.1%

Coauthors

All papers

Open in search
  1. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Taphoorn, Joerg-Christian Tonn, Jonathan Tsang, Roel G.W. Verhaak, Andreas von Deimling, Wolfgang Wick, Gelareh Zadeh, David A. Reardon, Kenneth Aldape, Martin J. van den Bent - Neuro-Oncology 2020 cited by 1,137

  2. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 3,829

  3. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 462

  4. Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

    Authors: , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 cited by 699

  5. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases

    Authors: , , , , , , , , , , , , , , , , - JAMA 2016 cited by 1,661

  6. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 cited by 1,192

  7. Glioblastoma

    Authors: , , - Handbook of clinical neurology 2016 cited by 474

  8. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2015 cited by 665

  9. Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 164

  10. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases

    Authors: , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2020 cited by 259

  11. Liquid biopsy in gliomas: A RANO review and proposals for clinical applications

    Authors: , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2022 cited by 134

  12. Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2024 cited by 68

  13. BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 135

  14. Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

    Authors: , , , , , , , , , , , , , , , , , - Neuro-Oncology 2018 cited by 205

  15. Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chas Haynes - Neuro-Oncology 2020 cited by 191

  16. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adam L. Cohen, Shivangi Vora, Michael V. Knopp, Ian F. Dunn, Priya Kumthekar, Jann N. Sarkaria, Susan M. Geyer, Xiomara W. Carrero, Maria Martinez‐Lage, Daniel P. Cahill, Paul D. Brown, Caterina Giannini, Sandro Santagata, Frederick G. Barker, Evanthia Galanis - Journal of Clinical Oncology 2022 cited by 105

  17. The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 cited by 244

  18. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katharine J. Drummond, Ian F. Dunn, Evanthia Galanis, Caterina Giannini, Roland Goldbrunner, Brent Griffith, Rintaro Hashizume, C. Oliver Hanemann, Christel Herold‐Mende, Craig Horbinski, Raymond Y. Huang, David H. James, Michael D. Jenkinson, Christine Jungk, Timothy J Kaufman, Boris Krischek, Daniel H. Lachance, Christian la Fougère, Ian Lee, Jeff C. Liu, Yasin Mamatjan, Tathiane M. Malta, Christian Mawrin, Michael McDermott, David G. Muñoz, Farshad Nassiri, Houtan Noushmehr, Ho‐Keung Ng, Arie Perry, Farhad Pirouzmand, Laila Poisson, Bianca Pollo, David R. Raleigh, Felix Sahm, Andrea Saladino, Thomas Santarius, Christian Schichor, David Schultz, Nils Ole Schmidt, Warren R. Selman, Andrew E. Sloan, Julian Spears, James M. Snyder, Suganth Suppiah, Ghazaleh Tabatabai, Marcos Tatagiba, Daniela Pretti da Cunha Tirapelli, J. C. Tonn, Derek S. Tsang, Michael A. Vogelbaum, Andreas von Deimling, Patrick Y. Wen, Tobias Walbert, Manfred Westphal, Adriana M Workewych, Gelareh Zadeh, Gelareh Zadeh, Kenneth Aldape - Neuro-Oncology 2019 cited by 274

  19. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tracy T. Batchelor, Michael Weller, Michael A. Vogelbaum, Matthias Preusser, Mitchel S. Berger, Mustafa Khasraw - Nature Medicine 2023 cited by 53

  20. Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daphne A. Haas‐Kogan, Shyam Tanguturi, Daniel Cagney, Ayal A. Aizer, Lisa Doherty, Maria Lavallee, Brittany Fisher-Longden, Shanna Dowling, Jack Geduldig, Fiona Watkinson, William Pisano, Seth Malinowski, Shakti Ramkissoon, Sandro Santagata, David M. Meredith, E. Antonio Chiocca, David A. Reardon, Brian M. Alexander, Keith L. Ligon, Patrick Y. Wen - Journal of Clinical Oncology 2023 cited by 50

  21. Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2021 cited by 81

  22. Imaging and diagnostic advances for intracranial meningiomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christel Herold‐Mende, Craig Horbinski, Raymond Y Huang, David James, Michael D. Jenkinson, Christine Jungk, Timothy J Kaufman, Boris Krischek, Daniel H. Lachance, Christian la Fougère, Ian Lee, Jeff C. Liu, Yasin Mamatjan, Alireza Mansouri, Christian Mawrin, Michael McDermott, David G. Muñoz, Farshad Nassiri, Houtan Noushmehr, Ho‐Keung Ng, Arie Perry, Farhad Pirouzmand, Laila Poisson, Bianca Pollo, David R. Raleigh, Felix Sahm, Andrea Saladino, Thomas Santarius, Christian Schichor, David Schultz, Nils Ole Schmidt, Warren R. Selman, Andrew E. Sloan, Julian Spears, James Snyder, Suganth Suppiah, Ghazaleh Tabatabai, Marcos Tatagiba, Daniela Pretti da Cunha Tirapelli, J. C. Tonn, Derek S. Tsang, Michael A. Vogelbaum, Andreas von Deimling, Patrick Y Wen, Tobias Walbert, Manfred Westphal, Adriana M Workewych, Gelareh Zadeh - Neuro-Oncology 2018 cited by 189

  23. A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

    Authors: , , , , , , , , , , , , , , - Neuro-Oncology 2014 cited by 166

  24. Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02

    Authors: , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 cited by 134